Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|May 30, 2023
Evaluation of diversity indices to estimate clonal dominance in gene therapy studiesGuillaume Corre, Anne Galy
Non-Coding RNA|July 27, 2022
Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA DysregulationDavid Israeli, Ai Vu Hong, Guillaume Corre, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2015
Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 VectorsMaxime Ferrand, Sylvie Da Rocha, Guillaume Corre, et al.
Human Gene Therapy|February 18, 2016
"RCL-Pooling Assay": A Simplified Method for the Detection of Replication-Competent Lentiviruses in Vector Batches Using Sequential PoolingGuillaume Corre, Michel Dessainte, Jean-Brice Marteau, et al.
Immunology|September 23, 2014
Hypoxic culture conditions enhance the generation of regulatory T cellsThi My Anh Neildez-Nguyen, Jérémy Bigot, Sylvie Da Rocha, et al.
Molecular Therapy. Methods & Clinical Development|June 14, 2019
An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical StressDavid Israeli, Jérémie Cosette, Guillaume Corre, et al.
Gene Therapy|February 23, 2022
Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cellsGuillaume Corre, Ababacar Seye, Sophie Frin, et al.
Human Gene Therapy|April 13, 2019
Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic AcidAlice Moussy, Nan Papili Gao, Guillaume Corre, et al.
Plos Biology|July 28, 2017
Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitmentAlice Moussy, Jérémie Cosette, Romuald Parmentier, et al.
Scientific Reports|September 11, 2024
Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 systemJuliette Lemoine, Auriane Dubois, Alan Dorval, et al.
Pageof 4